Breakthroughs and Market Evolution in Breast Cancer | APAC
We will discuss the current landscape and upcoming clinical and regulatory catalyst in breast cancer research. We will also preview key data due at the San Antonio Breast Cancer conference as antibody-drug conjugates look to change therapy for a broader set of patients.
Speakers
Max Nisen
Analyst
Bloomberg Intelligence
Tonia Kefala Stavridi
Disease Specialist
Bloomberg Intelligence
Tonia is a Disease Specialist under the Pharma & Biotech team at Bloomberg Intelligence, with a focus on breast cancer including analysis and curation of clinical data, disease epidemiology and addressable market opportunities. She holds a PhD in Biochemistry and MPhil in Biological Sciences from University of Cambridge as well as a BSc in Biotechnology from Imperial College London.